Table 6. Summary of study outcomes – Iron Treatment vs. Malaria Risk.

Author, Year	Study Design	Outcome	Exposure% (n)	Comparison to exposure% (n)	Risk estimate (95% CI)or p-value
Oppenheimer, 1986 [63]	Retrospective Cohort	Postnatal malaria- primigravida	Total Dose Iron Infusion 20·4% (11/54)	No Total Dose Iron Infusion 4·5% (3/67)	RR 4·55 (1·34–15·49) OR 5·46 (1·44, 20·7)
		Postnatal malaria- multigravida	Total Dose Iron Infusion 8·4% (8/95)	No Total Dose Iron Infusion 7·6% (14/184)	RR 1·11 (0·48–2·54) OR 1·12 (0·45, 2·76)
Byles, 1970 [62]	Prospective Cohort	Generalized reactions after total dose iron infusion	Total dose iron+Concurrent CQ 1·5% (7/462)	Total dose iron+No concurrent CQ 8·6% (39/455)	OR 0·16 (0·07–0·37) RR 0·18 (0·08–0·39)
		PF parasitemia present among participants with generalized reactions after total dose iron infusion	Total dose iron+Concurrent CQ 0·0% (0/7)	Total dose iron+No concurrent CQ 28·2% (11/39)	p = 0·17

CI: confidence interval. CQ: chloroquine. OR: odds ratio. PF: Plasmodium falciparum. RR: risk ratio.